Related Experiment Video
Updated: Jun 19, 2026
07:27
The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury
Published on: October 21, 2017
THE EFFECT OF VARIOUS DIETS ON THE LIVER DAMAGE CAUSED BY EXCESS CYSTINE
1Research Service, First Division, Welfare Hospital, Department of Hospitals, City of New York, and the Department of Medicine, College of Physicians and Surgeons, Columbia University, New York.
The Journal of Experimental Medicine
|October 30, 2009
Summary
Diet composition significantly impacts liver damage caused by excess dietary cystine in rats. Specific diets can alter the severity and progression of liver lesions like hemorrhage, necrosis, and cirrhosis.
Area of Science:
- Toxicology
- Nutritional Science
- Hepatology
Background:
- Excessive dietary cystine can induce liver lesions.
- The specific mechanisms and modifiable factors influencing these lesions require further investigation.
Purpose of the Study:
- To investigate the effects of various diets on liver lesions induced by excess dietary cystine in rats.
- To determine how dietary composition modifies the pathogenesis of cystine-induced liver damage.
Main Methods:
- 130 rats were fed 9 different diets containing 5% or 10% cystine.
- Liver lesions, including hemorrhage, necrosis, cirrhosis, and fatty infiltration, were assessed.
- The impact of specific dietary components (fat, protein, choline) was evaluated.
Main Results:
- Low-fat diets reduced hemorrhage severity.
- Synthetic diets exacerbated necrosis.
- High lard and cod liver oil diets delayed cirrhosis, unlike butter.
- Fatty infiltration occurred primarily with low-protein, high-fat diets.
- Choline inhibited fatty infiltration but not overall cystine damage.
Conclusions:
- Dietary interventions can modify the development and severity of liver lesions caused by excess cystine.
- The relationship between fatty infiltration and cirrhosis in this context is not direct.
- Understanding these dietary interactions is crucial for managing cystine-induced hepatotoxicity.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...